We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
23 hedge funds and large institutions have $1.79M invested in Atossa Therapeutics in 2020 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 1
91% more call options, than puts
Call options by funds: $63K | Put options by funds: $33K
77% more funds holding
Funds holding: 13 → 23 (+10)
51% more capital invested
Capital invested by funds: $1.18M → $1.79M (+$603K)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
0.25% more ownership
Funds ownership: 0.23% → 0.47% (+0.25%)
Holders
23
Holders Change
+10
Holders Change %
+76.92%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
4
Reduced
3
Closed
1
Calls
$63K
Puts
$33K
Net Calls
+$30K
Net Calls Change
-$8K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$421K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$282K |
| 3 |
Renaissance Technologies
New York
|
+$238K |
| 4 |
Two Sigma Investments
New York
|
+$134K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$78.5K |
